Brazil approves final tests of J&J virus vaccine
Brazilian health regulators said Tuesday they had approved Johnson & Johnson’s experimental vaccine against the new coronavirus for the final stage of clinical trials, the fourth vaccine to receive widespread testing in the hard-hit country.
The US pharmaceutical company’s subsidiary Janssen will test the vaccine on 7,000 volunteers across seven states in Brazil, part of a group of up to 60,000 worldwide, health regulator Anvisa said in a statement.
Via Asia Times